1. Home
  2. OLMA vs CINT Comparison

OLMA vs CINT Comparison

Compare OLMA & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • CINT
  • Stock Information
  • Founded
  • OLMA 2006
  • CINT 1995
  • Country
  • OLMA United States
  • CINT Brazil
  • Employees
  • OLMA N/A
  • CINT N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • CINT EDP Services
  • Sector
  • OLMA Health Care
  • CINT Technology
  • Exchange
  • OLMA Nasdaq
  • CINT Nasdaq
  • Market Cap
  • OLMA 560.7M
  • CINT 670.2M
  • IPO Year
  • OLMA 2020
  • CINT 2021
  • Fundamental
  • Price
  • OLMA $10.48
  • CINT $4.63
  • Analyst Decision
  • OLMA Strong Buy
  • CINT Strong Buy
  • Analyst Count
  • OLMA 5
  • CINT 4
  • Target Price
  • OLMA $24.00
  • CINT $7.20
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • CINT 390.4K
  • Earning Date
  • OLMA 11-11-2025
  • CINT 11-13-2025
  • Dividend Yield
  • OLMA N/A
  • CINT N/A
  • EPS Growth
  • OLMA N/A
  • CINT 34.66
  • EPS
  • OLMA N/A
  • CINT 0.25
  • Revenue
  • OLMA N/A
  • CINT $452,826,000.00
  • Revenue This Year
  • OLMA N/A
  • CINT $12.12
  • Revenue Next Year
  • OLMA N/A
  • CINT $12.92
  • P/E Ratio
  • OLMA N/A
  • CINT $18.67
  • Revenue Growth
  • OLMA N/A
  • CINT 1.02
  • 52 Week Low
  • OLMA $2.86
  • CINT $4.42
  • 52 Week High
  • OLMA $13.51
  • CINT $8.00
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 70.04
  • CINT 31.28
  • Support Level
  • OLMA $8.01
  • CINT $4.80
  • Resistance Level
  • OLMA $11.54
  • CINT $5.05
  • Average True Range (ATR)
  • OLMA 0.79
  • CINT 0.25
  • MACD
  • OLMA 0.14
  • CINT -0.07
  • Stochastic Oscillator
  • OLMA 72.61
  • CINT 11.54

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About CINT CI&T Inc

CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

Share on Social Networks: